Protective Efficacy and Immunologic Mechanism of the Recombinant Subunit Vaccine Against Actinobacillus Pleuropneumoniae in Mice
SHAO Mei-li,LIU Si-guo,WANG Chun-lai,WANG Yong,GONG Qiang,YIN Xun-nan,GUO She-ping,LIU Jian-dong,TONG Heng-min
DOI: https://doi.org/10.3321/j.issn:0578-1752.2007.04.024
2007-01-01
Abstract:【 Objective 】 To construct a multi-component recombinant subunit vaccine that could provide favorable cross-protection,which provides data for the research of novel porcine contagious pleuropneumonia(PCP) vaccines.【Method】Six major virulence factors of Actinobacillus pleuropneuminiae(APP),rApxⅠ,rApxⅡ,rApxⅢ,rApxⅣ,rOMP and rApfa were recombinantly expressed. Using the inactivated vaccine of APP serotype 1(5×108cfu) as group Ⅰ,the recombinants of rApxⅠ,rApxⅡ,rApxⅢ and rOMP as group Ⅱ,that of rApxⅠ,rApxⅡ,rApxⅢ,rApxⅣ,rApfa and rOMP as group Ⅲ,and PBS as the control group,the tests of immuno-protection against challenge were performed respectively,in which BALB/c mice were immunized three times at two week intervals and challenged with serotype 1(5×109cfu) and serotype 2(5×1010cfu)intranasally at the seventh day after the third immunization.【Result】The results suggested that group Ⅱ had a higher antibody level to four antigens and IL-2 production than others(P0.05). It had a slightly higher lymphocytes proliferation than others(P0.05). The protective efficacy against serotype 1of group II(9/10) was obviously better than group Ⅰ(6/10),group Ⅲ(5/10) and the control group(0/10),and the protective efficacy against serotype 2 of that(no lung lesion) was obviously better than others(typical lung lesion).,which demonstrated that the antibody level had a positive correlation to protective efficacy. 【Conclusion】The recombinant subunit vaccine containing ApxⅠ,ApxⅡ,ApxⅢ and OMP provided significantly crossing protection by simutaneously stimulating humoral immunity and cell immunity.